New Submissions Are Not Currently Being Accepted
Samples sent after April 10, 2024 will be put on hold.
Viewing desktop version: Switch to Mobile
Kangaroo
ID: 1672
| ID: | 1672 |
|---|---|
| Name: | Kangaroo |
| Other Names: | |
GC/MS: The GC/MS Lab Test |
|
Description
Microgram: The DEA Northeast Laboratory (New York, New York) recently received a polydrug submission which included 86 tan colored tablets with a Kangaroo logo on one face and a half-score on the opposite face, total net mass 15.4 grams, suspected Ecstasy [...]. The tablets were purchased in Philadelphia by the DEA Philadelphia Division. Analysis by GC/IRD, GC/MSD, FTIR, HPLC, CE, and also GC/MS after TFAP derivatization, indicated 28 mg of methamphetamine and 21 mg of 3,4-methylenedioxymethamphetamine (MDMA) per tablet (salt forms not determined). Unusually, the isomeric composition of the methamphetamine was approximately 87 percent l- and 13 percent d-. This is the first time the Northeast Laboratory has encountered l-methamphetamine with MDMA in an ecstasy tablet.